Zogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer's shares up as much as 26 percent.



Latest News

Los Angeles Times: Fountain Valley PONY Mustang squad wins Super Region opener

USA Today: Meryl Streep passes the 'Mamma Mia 2' spotlight to Lily James and a new generation

Daily Mail: The hosts of Studio 10 perform cringeworthy Spice Girls rendition

Daily Mail: Video: Model says black models were discriminated against at casting

Daily Mail: Guardiola bemoans absence of resting World Cup players

Daily Mail: N.Korea economy shrinks at sharpest rate in 20 yrs as...

Daily Mail: DHL heir on run after failing drugs test in Palau

Daily Mail: Studio 10's co-hosts wear pop star-themed outfits

Daily Mail: Sri Lanka wins toss, to bat 1st in 2nd test vs South...

Daily Mail: Brazilian police arrest plastic surgeon `Dr Bumbum´...

CNBC: Investment portfolios should be 'defensive' amid volatility

CNBC: Indonesia's central bank keeps interest rates unchanged

Reuters: 'Duck boat' capsizes in Missouri, kills at least eight: police

Jpost: Singaporean company director charged for supplying luxury goods to N.Korea

FOX: Trump 'relentless' against Russia, won't let Kremlin question US officials, Pompeo tells FOX

CNN: JPMorgan's plan to help Chicago's poorest neighborhoods

CNN: Image of man sitting in wreckage captures heartbreak after Iowa tornadoes

USA Today: McBride scores 27, Aces top Mercury 85-82

Daily Mail: FOREX-Yuan slumps, dollar on defensive after Trump...

Daily Mail: Democrats wrestle with election-year message on health...

Daily Mail: Translators stay in shadows, but Dems want Trump's to...

Times of Israel: With war looming, Israel girds for more violence in Gaza

WashingtonPost: DNA Testing Unlocks Secrets But Leaves Footprints: QuickTake

17 Related Articles from 2018-07-12